CONTINGUT

Destacados

HIVACAT

CCR5 / CXCR4 co-receptor tropism prediction in chronically HIV-1-infected subjects with suppressed viremia using ultradeep sequencing of the V3 loop of gp160 in total and episomal PBMC-associated HIV-1 DNA

Entitat finançadora: Pfizer Spain, S.A.

Entitat(s) participant(s):

Investigador(s) responsable(s): Roger Paredes

Epidemiologia Molecular